P rimary tumors of the facial nerve are uncommon le sions. Facial nerve schwannomas of the CPA and/or IAC are the most often encountered facial nerve tu mors and may be mistaken for vestibular schwannomas. We present a series of 4 patients with "atypical" tumors of the facial nerve based on 1) location (not involving the CPA or IAC) and/or 2) unusual histological findings. Although individually very rare, these atypical tumors in aggregate contribute significantly to pathology of the fa cial nerve. The goal of the present study is to highlight the diversity of conditions affecting the facial nerve with a review of the relevant literature and discussion of nu ances in diagnostic features. The role of operative man agement and surgical approach will also be discussed.
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P rimary tumors of the facial nerve are uncommon le sions. Facial nerve schwannomas of the CPA and/or IAC are the most often encountered facial nerve tu mors and may be mistaken for vestibular schwannomas. We present a series of 4 patients with "atypical" tumors of the facial nerve based on 1) location (not involving the CPA or IAC) and/or 2) unusual histological findings. Although individually very rare, these atypical tumors in aggregate contribute significantly to pathology of the fa cial nerve. The goal of the present study is to highlight the diversity of conditions affecting the facial nerve with a review of the relevant literature and discussion of nu ances in diagnostic features. The role of operative man agement and surgical approach will also be discussed.
Methods
Retrospective Chart Review
The charts of all patients with tumors of the facial nerve treated between 2008 and 2011 by the senior au thor (G.P.L.) were retrospectively reviewed. Patients un dergoing observation with serial MRI and those who were treated with upfront radiosurgery and for whom tissue diagnosis was not available were excluded. In ad dition, patients with suspected vestibular schwannoma, facial nerve schwannoma, neurofibromatosis Type 2, and metastatic disease were also excluded. Preoperative and postoperative imaging studies including CT scanning of the temporal bone and MRI were reviewed by an inde pendent neuroradiologist. Facial nerve outcomes were evaluated based on HouseBrackmann grade at presenta tion and at last followup (Table 1) .
Atypical tumors of the facial nerve: case series and review of the literature
Literature Review
A systematic search was performed using the PubMed and MEDLINE databases to identify case series involving facial nerve hemangiomas, facial nerve menin giomas, and facial nerve glomus tumors ( Table 2) . Ini tial key words included "facial nerve hemangioma" and "intratemporal hemangioma," which yielded 218 results. After systematic review, we were able to locate 9 com plete articles with case reports in the Englishlanguage literature. When searching for case reports discussing facial nerve meningiomas, we used the key words "fa cial nerve meningioma." This yielded 33 results, of which 7 were complete articles. Finally, "facial nerve glomus tumor" and "paraganglioma facial nerve" were the key words used to locate case reports of glomus facialis tu mors. There were 156 resulting articles, most of which described the more common glomus jugulare. Our search yielded a total of 9 case reports in the literature to date. We excluded all case reports that refrained from disclos ing details related to presentation, diagnostics, and man agement, leaving 7 articles for review.
Results
A total of 12 patients with tumors of the facial nerve were identified during the study period. Preoperatively identified facial nerve schwannomas treated with up-front radiosurgery (n = 2) or with resection and cable grafting (n = 2) were excluded from analysis. In addition, a facial nerve schwannoma diagnosed intraoperatively during surgery as a presumed vestibular schwannoma (n = 1) and a metastatic tumor to the CPA (n = 1) causing facial weakness were excluded from analysis. Finally, tumors that were believed to be facial nerve schwannomas based on imaging and that had been managed with a "wait and scan" approach were similarly excluded (n = 2). One tumor that was isolated to the mastoid segment of the facial nerve and that exhibited radiographic features believed to be unusual for schwan noma was found at surgery to be a schwannoma; this case was included because the tumor was not identified preop eratively as a facial nerve schwannoma (see Case 2 below). The charts of the 4 patients with "atypical" tumors of the facial nerve were reviewed and analyzed.
Patient Characteristics
There were 2 men and 2 women. The mean age was 53 years old. All 4 patients presented with some degree of facial paresis, except the patient in Case 3; the length of time from onset of facial weakness to diagnosis was 21 months. Three of the 4 patients had a history of remote Bell palsy, after which a complete recovery was made.
Surgical interventions included facial nerve decom pression (n = 3), partial tumor resection and/or biopsy (n = 3), and tumor resection with interposition cable graft (n = 1). The approach was via a middle fossa craniotomy (n = 2) or a transpetrosal one (n = 2). Tumor histology was consistent with a hemangioma of the facial nerve (n = 1), meningioma (n = 1), schwannoma (n = 1), and a glomus facialis tumor (n = 1).
The mean preoperative HouseBrackmann facial nerve grade was III. The mean HouseBrackmann facial nerve grade at last followup was II. There was no major perioperative morbidity or death.
Illustrative Cases
Case 1
This 52yearold woman presented with a 2month history of right facial weakness. She developed Bell palsy on the right side more than 10 years previously, which had resolved within a few days with steroids and antiviral medication. This time, however, she did not respond to steroids. For this reason, MRI and CT scanning of the temporal bone were performed. These studies showed a right 10 × 12-mm skull base lesion situated within the right mastoid with some degree of contrast enhance ment consistent with a neoplasm (Fig. 1) . Differential considerations included glomus tumor and schwannoma. On examination, the patient was intact except for facial weakness (HouseBrackmann Grade III). The patient un derwent a right transtemporal craniotomy including mas toidectomy and decompression of the sigmoid sinus with microsurgical resection of the extradural skull base para ganglioma and decompression of the vertical segment of the facial nerve from the facial recess to the stylomas toid foramen. Surgical pathology was compatible with paraganglioma. The patient had worsening facial paresis postoperatively (HouseBrackmann Grade VI) that at last followup (13 months) improved back to the preoperative level (HouseBrackmann Grade III); there has been no progression of residual tumor.
Case 2
This 77yearold man presented with left facial weak ness that progressed over a period of 9 months. Magnetic resonance imaging with and without contrast showed a left temporal tumor, which involved the vertical segment of the facial nerve (Fig. 2) . The CT scan showed an ex pansive lytic process involving the left facial nerve re gion. Differential diagnosis included neoplastic processes arising from the facial nerve or from the jugular fossa involving the facial nerve. On examination, he was in tact except for severe facial weakness (HouseBrackmann Grade VI). The patient underwent the following proce dures: postauricular intratemporal craniotomy with mi crosurgical resection of the facial nerve schwannoma, in terposition graft of the facial nerve with a collagen tubule and 15cm harvest of the sural nerve, parotidectomy, and tympanoplasty with ossicular reconstruction. The surgi cal specimen was compatible with a schwannoma (WHO Grade I). At last followup (12 months), the patient had no significant improvement in facial nerve function and was referred for a facial sling procedure.
Case 3
This 49yearold man presented with right ear full ness lasting 1 year and 1 episode of dizziness 2 years prior (from which he had a full recovery). Magnetic res onance imaging and CT temporal bone studies showed a right enhancing temporal bone mass and enlargement of the facial nerve along the geniculate ganglion, most consistent with hemangioma followed by facial nerve schwannoma and meningioma (Fig. 3) . On physical ex amination, the patient was intact. The patient underwent a combined transmastoid and middle fossa craniotomy with resection of extradural skull base tumor and tegmen reconstruction. Surgical pathology was compatible with meningioma (WHO Grade I). Although he continued to have some right ear pressure, the patient's otological ex amination revealed normal findings.
Case 4
This 37yearold woman presented with a 5year his tory of vertigo. Three years later she developed Bell pal sy. Since then, she has complained of left facial weakness and synkinesis and received Botox injections in January 2010. Despite this treatment, she continued to have fa cial weakness. Findings from initial imaging, including MRI performed 5 years earlier, were thought to be nega tive. Subsequent imaging demonstrated slight irregular enhancement of the labyrinth and geniculate segment of the facial nerve. Her CT scanning examination showed an ossified lytic spiculated lesion in the area of the ge niculate segment of the facial nerve (Fig. 4) . On physi cal examination, the patient was intact except for mild left facial asymmetry and HouseBrackmann Grade I-II left facial weakness. Differential diagnosis included an inflammatory process versus a benign neoplasm such as facial nerve schwannoma or hemangioma. The patient underwent a left middle fossa craniotomy for resection of the tumor and facial nerve decompression. Surgical pathology was compatible with hemangioma. Postopera tively, she did well and her face was symmetric (House Brackmann Grade I).
Discussion
We present a series of rare facial nerve tumors with features atypical from those seen in the more common facial nerve schwannoma, which in autopsy series may have an incidence as high as 0.8%. 36 Facial nerve schwan nomas typically involve the geniculate ganglion, IAC, and CPA (Fig. 5) . Facial nerve schwannomas, such as the case included here, entirely confined to the temporal bone are exceedingly rare.
Facial nerve hemangiomas were first described by Politzer in 1901. 25 Again, this lesion has a predilection for the geniculate ganglion. Once thought to occur here as re sult of pertinent anastomosis, it has recently been found to arise as a consequence of its dense capillary but anatomi cally distinct network. When compared with the neigh boring segments of the geniculate ganlgion (that is, the tym panic and labyrinthine segments), there are upward of 46 cases reported in the literature of facial nerve heman gioma involving the geniculate ganglion. 2 Hemangiomas are also commonly known as benign vascular tumors. There is evidence to prove that facial nerve hemangiomas should be correctly categorized as venous malformations, given the lack of internal elastic laminae noted on his tological examination. 1, 4 In fact, Benoit et al. 4 attempted to reclassify facial nerve hemangiomas using histologi cal and immunohistochemical markers in the context of commonly accepted vascular lesion nomenclature. The distinction is understood when the true definition is stud ied. Benign vascular tumors arise directly from cellular hyperplasia, whereas malformations arise from errors in vascular morphogenesis. 4 Facial nerve hemangiomas usually present in midlife, specifically between the 3rd and 6th decades. There ap pears to be an equal distribution of males and females. Approximately 97% of patients with atypical facial nerve tumors present with some degree of facial nerve deficit.
14 Quite often, there is a spectrum of motor deficit that var ies from hemifacial spasms to facial paresis. Hearing loss is also common and may be characterized as conductive if the horizontal segment of the facial nerve is involved or sensorineural if the tumor affects the labyrinthine seg ment or geniculate ganglion. Again, ipsilateral hearing loss is the most prevalent presenting symptom. Nonethe less, the deficit often is slow in progression or renders a recurrent episodic course, which allows us to make the distinction between other facial nerve tumors. Patients are often misdiagnosed and treated for idiopathic facial nerve weakness (Bell palsy), a much more common etiol ogy of facial nerve paresis. The temporal characteristic of facial paralysis is of utmost importance in diagnoses. With Bell palsy, 85% of patients experience recovery of facial paresis to HouseBrackmann Grade I or II in ap proximately 8-12 weeks, whereas patients with atypical facial nerve tumors, such as facial nerve hemangiomas, often experience a more indolent course without recovery of facial motor function. Uniquely, facial nerve hemangi oma size is not directly correlated to the extent of deficit. Small tumors (< 10 mm) may lend themselves to grave deficits. There is debate in the literature with respect to the etiology of the neurological deficit. Previous reports in the literature have claimed that facial nerve deficits arise as a consequence of direct compressive forces; new er schools of thought believe that there is an element of a vascular steal phenomenon wherein blood flow to the highly vascular facial nerve is detoured toward the tu mor, resulting in ischemic insult. 4, 35 For this reason, facial nerve schwannomas of similar size may lead to less se vere cranial nerve dysfunction. 26 The relationship between facial nerve hemangioma and cavernous malformations isolated to the seventh cra nial nerve is controversial. Deshmukh et al. 8 described 2 patients who presented with acute hearing loss and fa cial nerve paresis; MRI revealed hyperintense lesions, without contrast enhancement, which were found to have small cavernous malformations. Importantly, extraaxial cavernous malformations may also enhance following the administration of Gd, so the presence of enhancement is not sufficient to rule out the presence of a cavernous malformation. The incidence of these lesions is too low to determine whether these lesions are truly distinct from facial nerve hemangioma, or merely histological varia tions of the same clinicopathological entity.
Although meningiomas are the second most common tumor of the CPA, geniculate meningiomas are exceed ingly rare. 27 Although the etiology is unclear, noted as sociations with progesterone, breast cancer, and radiation therapy have been described. 17 Meningiomas arise from arachnoid villi, which are invaginations of the arachnoid mater along the walls of the dural and venous sinuses. They are also located along the neural foramina of the cranial nerves. Facial nerve meningiomas most likely arise from the arachnoid villi along the porus acousticus (opening between the CPA cistern and IAC) and gasse rian envelope. This can be explained embryonically. The seventh and eighth cranial nerves arise from a common primordium. At 5 weeks of gestation, the fibers of the facial nerve exit the neural tube along with a sheath of arachnoid and dura. Although the dura terminates at the IAC, the arachnoid may continue toward the geniculate ganglion and beyond as it gradually fuses with endoneu rium. 19, 31 Extracranial extension of a neural foramen me ningioma is quite rare. More commonly, the tumor would originate intracranially and extend extracranially.
Glomus tumors are also known as paragangliomas or chemodectomas that arise from chemoreceptor cell deriv atives of neural crest cells. They originate from paragan glionic tissue typically at the carotid bifurcation (carotid body tumors), jugular foramen (glomus jugulare), vagus nerve (glomus vagale), and tympanic plexus (glomus tym panicum). 21 They may occur sporadically or as a part of hereditary syndromes such as multiple endocrine neo plasia Type II (MEN II), von HippelLindau syndrome, and neurofibromatosis Type 1. 21 In 80% of hereditary cas es and 20% of sporadic cases, the patient presents with multiple lesions.
A landmark histological study by Guild in 1941 de scribed 73 temporal bone paragangliomas. 32 The thought is that the glomus tumor may arise from the Arnold nerve, an auricular branch of the vagus nerve that traverses through the mastoid canaliculi from the jugular bulb, su perior to the fallopian canal at the stylomastoid foramen, where an ascending branch merges with the facial nerve. This is the same nerve that gives rise to glomus jugulare and glomus tympanicum. 9 
Preoperative Evaluation
Any patient with a suspected tumor of the facial nerve should be evaluated with highresolution CT scanning of the temporal bone, MRI with and without contrast, and direct otoscopic examination. Large tumors involving the tympanic segment of the facial nerve may be visible on otoscopic examination. Gross features such as vascular ity may aid in diagnosis, and transcanal biopsy may be performed in select cases. Electroneurography may also be of assistance in select cases.
Careful review of preoperative radiographs may help to establish the diagnosis of facial nerve schwannoma, es pecially in the presence of geniculate ganglion enhance ment, anterior position of the tumor in the IAC, or linear enhancement of the facial nerve in the mastoid temporal bone. 38 Schwannomas will typically create a smooth but enlarged course along the fallopian canal and may be dif ferentiated from hemangiomas, which lack distinct mar gins and often contain bony spicules on thincut CT. They will also enhance on postcontrast T1weighted MRI.
Facial nerve hemangiomas are best visualized via highresolution CT scanning of the temporal bone, namely enlargement of the fallopian canal with a lesion exhibiting irregular margins, amorphous shape, and pos sibly intratumoral bony spicules. The typical honeycomb or sunburst radiographic appearance is indicative of an ossifying hemangioma. This occurs as a result of osteo clastic remodeling resulting in intralesional lamellar bony trabeculae. 4, 29 The honeycomb sign is pathognomonic for hemangioma and helps to differentiate between schwan noma and meningioma. Nevertheless, this is present only 50% of the time.
11 This is also known as an ossifying hemangioma. 29 Magnetic resonance imaging of the brain, with thincut sequences through the temporal bone at the IAC, is used if the lesion is not visualized. One would expect to see iso, hyper, or variable intensity on T1 weighted images and hyperintensity on T2weighted im ages as well as enhancement with Gd contrast. Of note, one would expect normal variations of mild to moderate enhancement of certain aforementioned highly vascular ized segments of the facial nerve, namely the geniculate ganglion and tympanic and labyrinthine segments.
Circumferential expansion of the facial nerve canal with wellpreserved margins and smooth architecture are typical findings in cases of glomus facialis and are findings comparable to characteristics of schwannoma on CT scanning. Magnetic resonance imaging of the tempo ral bone, when performed, may reveal a pathognomonic saltandpepper pattern as described by Olsen et al. 33 in paragangliomas larger than 2 cm. Otherwise, the lesion has been noted to show hypointensity to muscle on T1 weighted imaging and heterogeneous enhancement with Gd contrast injection. On T2weighted imaging, there is isointensity to muscle. 18 Angiographic findings include hypervascularity, an enlarged feeding artery, and possible draining vein. This often assists in diagnosis, as rapid ar teriovenous shunting is not seen in hemangiomas.
Management
Due to their rarity, there is little guidance in the lit erature for the appropriate management of facial nerve tumors. Recommendations may be reasonably extrapo lated from the approach to the more common facial nerve schwannoma. Many authors, including Shirazi et al., 37 have advocated conservative treatment of facial neuromas when patients present without facial motor and hearing deficits. 20, 28 Treatment strategies include radiological ob servation, drainage of any cystic component of the tumor for histological diagnosis, and/or bony decompression of the tumor. 37 Even decompression may lend itself to a delayed management approach in attempts at preserv ing residual nerve function. Nevertheless, if the lesion is symptomatic, resection with attempts at anatomical con tinuity is the gold standard. Surgical approaches include the most commonly used translabyrinthine approach, as well as the retrosigmoid approach, transmastoid or mid dle fossa approach, combined middle fossa-transmastoid approach, and transmastoid-transparotid approach. This is often performed with a cable nerve graft interposition of either the sural or greater auricular nerve. Falcioni et al. 12 stated that the chances of satisfactory facial nerve recovery decreases significantly postoperatively if resec tion is not performed within the 1st year of initial clinical facial nerve dysfunction.
Hemangiomas of the facial nerve at the geniculate ganglion are best approached through the middle fossa. If the vertical segment of the facial nerve is involved and hearing is preserved, a transmastoid approach appears to obtain the best visualization. Often a combined approach is appropriate. Upon dissection a soft, dark red, or even blue, easily dissectible mass will be encountered. As a consequence, the facial nerve is often salvageable. Sur gery should be offered within the 1st year of diagnosis, prior to perineural fibrosis, or actual neural infiltration develops, making resection more difficult.
1 Facial nerve decompression and removal of any compressive bony spicules may prolong facial function and minimize the chances of postoperative worsening of facial paresis. Ag gressive resection will likely exacerbate preexisting facial paresis and is warranted only in cases of highgrade facial nerve dysfunction (HouseBrackmann Grade V or VI).
If resection is appropriate, cable grafting such as with a greater auricular nerve graft may be used. This in tervention may preserve facial nerve function in the range of 50%-75%. 10 
Role of Radiosurgery
Recently, our group has published on the changing paradigm for treatment of facial nerve schwannoma, with an increased reliance on radiosurgery for the treatment of these tumors. 39 This is often performed on the basis of MRI and CT imaging alone (that is, without tissue di agnosis). While radiosurgery has had generally favorable results for the treatment of facial nerve schwannoma, the role of radiosurgery in these atypical tumors, especially facial nerve hemangiomas, is less clear.
Other rare causes of facial nerve paresis from tumor involvement of the intratemporal facial nerve include epi dermoid (cholesteatoma), metastasis, and direct invasion from skull base carcinoma. The facial nerve perineurium serves as a gateway to the temporal bone for neoplasms such as parotid mucoepidermoid carcinoma, benign pleo morphic adenoma of the parotid gland, and squamous cell carcinoma. 16 Tumors extrinsic to the intratemporal segment including primary temporal bone tumors, pon tine gliomas, and parotid tumors may also affect facial nerve function.
Conclusions
Much of how we approach facial nerve tumors arises from experience with the natural history of facial nerve schwannomas, characterized by indolent symptomatic progression and slow growth. However, less is known about the natural history of these atypical lesions. In the absence of sufficient clinical data to prove otherwise, a conservative approach may be warranted. Open questions include the role of radiosurgery, facial nerve decompres sion, and indications for resection of tumor and cable grafting for these rare lesions.
